Indeed, TG68 seems able to enhance the expression of neurotrophic factors (i.e., IGF, FGF, GDNF, and BDNF), promoting a shift from the pro-inflammatory phenotype toward the anti-inflammatory M2 phenotype, thereby potentially ameliorating neuroinflammation associated with various neurological disorders. This evidence concerns the gene GDNF and nervous system disorder.